Several scenarios are now converging to create the suspicion this was the case - including conditional approval for an HIV pill by Chinese officials, AIDS-like immunodepression from the jab and an Indian paper that was quickly retracted.
STORY AT-A-GLANCE
- July 25, 2022, Chinese officials granted conditional approval to Azvudine, an HIV drug, to be used as a COVID treatment
- Use of the HIV drug has reignited interest in early evidence suggesting SARS-CoV-2 is a bioweapon augmented with parts of the HIV virus
- In late January 2020, Indian researchers published a paper claiming segments of the viral RNA appeared more closely related to HIV than other coronaviruses. The researchers even said SARS-CoV-2 responded to HIV medications
- The Indian paper was quickly retracted, but not before catching the attention of the late Luc Montagnier, a world-renowned virologist who won the Nobel prize for his discovery of HIV. Montagnier insisted the Indian researchers were correct in their assessment, and had been forced to retract the paper “after enormous pressure”
- Several scenarios are now converging to create the suspicion that getting an HIV vaccine to market may be a goal behind COVID. The COVID jab is causing AIDS-like immunodepression, which helps create the perception that we have an urgent need for an HIV vaccine
July 25, 2022, Chinese officials granted conditional approval to an HIV drug to be used as a COVID treatment. As reported by Reuters:1
“The Azvudine tablet, which China approved in July last year to treat certain HIV-1 virus infections, has been given a conditional green light to treat adult patients with ‘normal type’ COVID, the National Medical Products Administration said in a statement.
‘Normal type’ COVID is a term China uses to refer to coronavirus infections where there are signs of pneumonia, but the patients haven’t reached a severe stage ... In a late-stage clinical trial, 40.4% of patients taking Azvudine showed improvement in symptoms seven days after first taking the drug, compared with 10.9% in the control group ...”The use of the HIV drug has reignited interest in early evidence suggesting SARS-CoV-2 is a bioweapon augmented with parts of the HIV virus.
